Cooper Cos
The Cooper Companies, Inc. is an American medical device company operating across contact lens optics and women's healthcare markets. The company conducts business through two major business units: CooperVision and CooperSurgical. CooperVision manufactures soft contact lenses for vision conditions such as astigmatism, presbyopia, and myopia, while CooperSurgical supplies medical devices and fertility solutions for women's health. Primary revenue drivers are global volume sales of specialty contact lenses alongside surgical and reproductive products sold to healthcare providers. The Cooper Companies holds a leading global market position in soft contact lenses and toric lens technologies. The company is headquartered in San Ramon, California, and its shares are listed on the Nasdaq Global Select Market.
34 of the funds FundTelligence covers report a position in Cooper Cos.
- Legal name
- Cooper Cos Inc/The
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 34
- Exposure themes
- Fertility, Reproductive health, Reproductive Health, Treatment, Women's Health
Funds holding Cooper Cos
- Storebrand Like Muligheter — Storebrand · 2.99 % (full portfolio disclosed, October 2026)
- Storebrand Global Solutions — Storebrand · 2.16 % (full portfolio disclosed, October 2026)
- DNB Fund Women's Health — DNB · 1.74 % (full portfolio disclosed, August 2026)
- Franklin Mutual U.S. Value Fund — Franklin Templeton · 1.67 % (full portfolio disclosed, September 2026)
- T. Rowe Price US Smaller Companies Equity Fund — T. Rowe Price · 1.03 % (full portfolio disclosed, September 2026)
- Handelsbanken Infrastruktur och Beredskap — Handelsbanken · 0.56 % (full portfolio disclosed, October 2026)
- DNB Global Core — DNB · 0.17 % (full portfolio disclosed, September 2026)
- Storebrand Global Optimised — Storebrand · 0.15 % (full portfolio disclosed, October 2026)
Showing the 8 largest of 34 funds holding it.